Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:1
|
作者
Moodi, Farzan [1 ,2 ]
Naseripour, Masood [1 ,2 ,3 ]
Zand, Amin [1 ,2 ]
Mirshahi, Reza [1 ,2 ]
Moodi, Vihan [4 ]
Alemzadeh, Sayyed Amirpooya [1 ,2 ]
Falavarjani, Khalil Ghasemi [1 ,2 ,3 ,5 ]
机构
[1] Iran Univ Med Sci, Senses Hlth Inst 5, Eye Res Ctr, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[2] Iran Univ Med Sci, Senses Hlth Inst 5, Dept Ophthalmol, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[3] Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[5] Rassoul Akram Hosp, Eye Res Ctr, Sattarkhan Niaiesh St, Tehran 14456, Iran
关键词
Central Serous Chorioretinopathy; Fluorescein Angiography; Indocyanine Green Angiography; Photodynamic Therapy; VERTEPORFIN;
D O I
10.18502/jovr.v19i1.15420
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the outcomes of fluorescein angiography (FA)-guided and indocyanine green angiography (ICGA)-guided half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: In this retrospective comparative study, medical records of eyes with chronic CSC who underwent half-dose PDT were reviewed. A retina specialist performed FA-guided half-dose PDT, and the other performed ICGA-guided treatment. The success of applying PDT in the resolution of subretinal fluid was compared between the FA- and ICGA-guided methods. Results: Eighty-two eyes of 73 patients (41 eyes in each group) received half-dose PDT. After halfdose PDT, a significant improvement in the best-corrected visual acuity (BCVA) was found at the time of the last follow-up in both groups (both P < 0.001), with no significant intergroup difference. Central subfield and subfoveal choroidal thicknesses decreased significantly in both groups at the last follow-up (all P < 0.05), with no significant differences between the groups. Subretinal fluid (SRF) resolved in all eyes, and no persistent SRF was detected during the follow-up period. Conclusion: FA-guided and ICG-guided half-dose PDT may have similar efficacy for the treatment of chronic CSC.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [31] Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
    Fujita, Kyoko
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Imamura, Yutaka
    Tanaka, Etsuko
    Mizutani, Yoshihiro
    Mizota, Atsushi
    Yuzawa, Mitsuko
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1681 - 1687
  • [32] OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy
    Teussink, Michel M.
    Breukink, Myrte B.
    van Grinsven, Mark J. J. P.
    Hoyng, Carel B.
    Klevering, B. Jeroen
    Boon, Camiel J. F.
    de Jong, Eiko K.
    Theelen, Thomas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (09) : 5229 - 5237
  • [33] Indocyanine green angiography in chronic central serous chorioretinopathy
    Gajdzik-Gajdecka, Urszula
    Dorecka, Mariola
    Nita, Ewa
    Michalska, Anna
    Miniewicz-Kurkowska, Joanna
    Romaniuk, Wanda
    MEDICAL SCIENCE MONITOR, 2012, 18 (02): : CR51 - CR57
  • [34] Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
    Miao Zeng
    Xiao Chen
    Yanping Song
    Chunyan Cai
    BMC Ophthalmology, 22
  • [35] CENTRAL SEROUS CHORIORETINOPATHY AND INDOCYANINE GREEN ANGIOGRAPHY
    PICCOLINO, FC
    BORGIA, L
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1994, 14 (03): : 231 - 242
  • [36] Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
    Kinoshita, Takamasa
    Mitamura, Yoshinori
    Mori, Terumi
    Akaiwa, Kei
    Semba, Kentaro
    Egawa, Mariko
    Mori, Junya
    Sonoda, Shozo
    Sakamoto, Taiji
    PLOS ONE, 2016, 11 (09):
  • [37] Half-Dose Verteporfin Combined with Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Liu, Chun-Fu
    Chen, Lee-Jen
    Tsai, Shawn H.
    Lai, Chi-Chun
    Chan, Wei-Chun
    Wu, Wei-Chi
    Wang, Nan-Kai
    Chen, Kuan-Jen
    Hwang, Yih-Shiou
    Chen, Yen-Po
    Yeung, Ling
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 30 (05) : 400 - 405
  • [38] Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study
    Pinto, Christophe
    Sousa, Keissy
    Oliveira, Eliana
    Mendonca, Luis
    Gentil, Rita
    Queiros, Lara
    Falcao, Manuel
    SEMINARS IN OPHTHALMOLOGY, 2022, 37 (02) : 153 - 157
  • [39] A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
    Toklu, Yasin
    Cakmak, Hasan Basri
    Yorgun, Mucella Arikan
    Ergun, Sule Berk
    Simsek, Saban
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (04) : 681 - 688
  • [40] Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence
    Wookyung Park
    Mirinae Kim
    Rae Young Kim
    Young-Hoon Park
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 2155 - 2161